VectorY Therapeutics
a clinical-stage biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases
Biotechnology
Amount raised
$82.9M
Round
—
Date raised
November 11, 2026
Founded
—
CompanyVectorY Therapeutics
IndustryBiotechnology
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About VectorY Therapeutics
a clinical-stage biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases
- How much did VectorY Therapeutics raise?
- VectorY Therapeutics raised $82.9M on November 11, 2026.
- Who founded VectorY Therapeutics?
- No founder is listed for VectorY Therapeutics yet.